Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Naldi

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
The British Journal of Dermatology|April 19, 2017
Finding a HOME for outcome measures in atopic dermatitisL Naldi
Dermatologic Clinics|July 1, 1995
PsoriasisL Naldi
The British Journal of Dermatology|April 27, 2016
Conflicts of interest among academic dermatologists: freedom or constraint?L Naldi
The British Journal of Dermatology|June 16, 2020
Risk of infections in psoriasis. A lesson to learn during the SARS-CoV-2 pandemicL Naldi
The British Journal of Dermatology|February 13, 2016
Prediction of high total naevus count to estimate melanoma risk. We need more, don't we?L Naldi, S Cazzaniga
Annales De Dermatologie Et De Venereologie|June 28, 2006
[Psoriasis and cancer: more than a chance link]L Naldi, L Chatenoud
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|May 14, 2014
Epidemiology of cutaneous drug-induced reactionsL Naldi, S Crotti
Dermatology (Basel, Switzerland)|January 9, 2001
Exploring the causes of cutaneous B-cell lymphoma: we should learn from the Lyme disease experienceL Naldi, C Minelli
The British Journal of Dermatology|June 13, 2008
Distribution of congenital melanocytic naevi and congenital naevus-like naevi in a survey of 3406 Italian schoolchildrenS Gallus, L Naldi,
The British Journal of Dermatology|July 23, 2011
Methotrexate, a drug for the years to comeL Naldi, M Saunes
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
The British Journal of Dermatology|April 19, 2017
Finding a HOME for outcome measures in atopic dermatitisL Naldi
Dermatologic Clinics|July 1, 1995
PsoriasisL Naldi
The British Journal of Dermatology|April 27, 2016
Conflicts of interest among academic dermatologists: freedom or constraint?L Naldi
The British Journal of Dermatology|June 16, 2020
Risk of infections in psoriasis. A lesson to learn during the SARS-CoV-2 pandemicL Naldi
The British Journal of Dermatology|February 13, 2016
Prediction of high total naevus count to estimate melanoma risk. We need more, don't we?L Naldi, S Cazzaniga
Annales De Dermatologie Et De Venereologie|June 28, 2006
[Psoriasis and cancer: more than a chance link]L Naldi, L Chatenoud
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|May 14, 2014
Epidemiology of cutaneous drug-induced reactionsL Naldi, S Crotti
Dermatology (Basel, Switzerland)|January 9, 2001
Exploring the causes of cutaneous B-cell lymphoma: we should learn from the Lyme disease experienceL Naldi, C Minelli
The British Journal of Dermatology|June 13, 2008
Distribution of congenital melanocytic naevi and congenital naevus-like naevi in a survey of 3406 Italian schoolchildrenS Gallus, L Naldi,
The British Journal of Dermatology|July 23, 2011
Methotrexate, a drug for the years to comeL Naldi, M Saunes
Pageof 19